Successful rescue of refractory, severe antibody mediated rejection with splenectomy

被引:59
作者
Kaplan, Bruce
Gangemi, Antonio
Thielke, James
Oberholzer, Jose
Sankary, Howard
Benedetti, Enrico
机构
[1] Univ Illinois, Dept Med, Div Transplant Med, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Med, Divt Transplantat, Chicago, IL 60612 USA
关键词
refractory antibody-mediated rejection; splenectomy; kidney transplant;
D O I
10.1097/01.tp.0000243739.31440.2b
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibody-mediated rejection (AMR) commonly occurs after transplantation of ABO-incompatible and sensitized renal transplant. Treatment regimens commonly include a combination of plasmapheresis (PL) and intravenous immunoglobulin (IVIG). However, some cases of AMR remain refractory to treatment. We report a case series of four patients with AMR refractory to standard therapy (ST) who resolved after splenectomy. Four living donor kidney transplant recipients were diagnosed with AMR. Two patients were ABO incompatible, one was cross-match positive and one had no obvious predisposing factors. After failure of therapy with corticosteroids, PL, IVIG, Thymoglobulin, and Rituximab (three patients) or Campath (one patient), AMR was treated with laparoscopic splenectomy. After an average of I I days of ST, laparoscopic splenectomy was performed for rescue. The urinary output improved immediately in all patients, serum creatinine levels decreased within 48 hr, and ABO titers fell in the ABO-incompatible patient and the cross-match became negative in the two sensitized patients. Splenectomy may play a role in the treatment of AMR refractory to ST.
引用
收藏
页码:99 / 100
页数:2
相关论文
共 11 条
[1]  
AIKAWA A, 2004, CLIN TRANSPL, V135, P42
[2]   PLASMAPHERESIS - ADJUNCTIVE TREATMENT FOR STEROID-RESISTANT REJECTION IN RENAL-TRANSPLANTATION [J].
BANOWSKY, LHW ;
CORTESE, J ;
LUTTON, JJ ;
SAUNDERS, PH .
JOURNAL OF UROLOGY, 1984, 131 (01) :14-16
[3]   Rituximab as treatment for refractory kidney transplant rejection [J].
Becker, YT ;
Becker, BN ;
Pirsch, JD ;
Sollinger, HW .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :996-1001
[4]   Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients [J].
Csapo, Z ;
Benavides-Viveros, C ;
Podder, H ;
Kahan, BD .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (05) :2032-2036
[5]   Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action [J].
Jordan, SC ;
Quartel, AW ;
Czer, LSC ;
Admon, D ;
Chen, G ;
Fishbein, MC ;
Schwieger, J ;
Steiner, RW ;
Davis, C ;
Tyan, DB .
TRANSPLANTATION, 1998, 66 (06) :800-805
[6]   SPLENIC STUDIES .1. SUSCEPTIBILITY TO INFECTION AFTER SPLENECTOMY PERFORMED IN INFANCY [J].
KING, H ;
SHUMACKER, HB .
ANNALS OF SURGERY, 1952, 136 (02) :239-242
[7]   Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen [J].
Kruetzmann, S ;
Rosado, MM ;
Weber, H ;
Germing, U ;
Tournilhac, O ;
Peter, HH ;
Berner, R ;
Peters, A ;
Boehm, T ;
Plebani, A ;
Quinti, I ;
Carsetti, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (07) :939-945
[8]   T-lymphocyte subset distribution in human spleen [J].
Langeveld, M ;
Gamadia, LE ;
ten Berge, IJM .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) :250-256
[9]   IMMUNOGLOBULIN PREVENTS COMPLEMENT-MEDIATED HYPERACUTE REJECTION IN SWINE-TO-PRIMATE XENOTRANSPLANTATION [J].
MAGEE, JC ;
COLLINS, BH ;
HARLAND, RC ;
LINDMAN, BJ ;
BOLLINGER, RR ;
FRANK, MM ;
PLATT, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2404-2412
[10]  
Nolte MA, 2000, EUR J IMMUNOL, V30, P626